Ceftspn S 500mg/250mg Injection
Marketer
Spencure Biotech Pvt. Ltd.
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Ceftspn S 500mg/250mg Injection
Ceftriaxone and Sulbactam injection (500mg/250mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism halts bacterial proliferation, thereby controlling infection spread. Administration must be overseen by a medical professional; strict adherence to the prescribed dosage schedule is crucial. Complete the full course, even with symptom improvement, as premature cessation could compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate consultation. Seek immediate medical attention for allergic reactions like skin rashes, itching, swelling, or respiratory distress. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order blood tests and other assessments to monitor the medicine's effects.
Uses of Ceftspn S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Ceftspn S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceftspn S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftspn S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ceftspn S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Ceftspn S 500mg/250mg Injection, offer a dual-action approach to bacterial infection. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, complements this by neutralizing bacterial defenses, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent ingestion of alcohol and Ceftspn S 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ceftspn S 500mg/250mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to fetal development; clinical data in humans, however, remains scarce.
Breast feedingCAUTION
Administering Ceftspn S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Ceftspn S (500mg/250mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceftspn S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Ceftspn S 500mg/250mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Ceftspn S 500mg/250mg Injection is not suggested for those experiencing mild or moderate liver dysfunction.
What if you forget to take Ceftspn S 500mg/250mg Injection :
Omit a Ceftspn S 500mg/250mg Injection dose? Seek medical advice immediately.
Facts to Know About Ceftspn S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently